Responsibility for the safety, integrity and scientific validity of the trials fell to 12 experts of the COVID-19 Vaccine Data and Safety Monitoring...
Strong immune responses to unchanging, conserved parts of the 2009 H1N1 pandemic flu virus suggest strategies for effective universal vaccinesCredit: Guthmiller et al.
...
National Cancer Institute support brings cancer researchers together to share key findings LA JOLLA–Researchers are about to welcome a new one-stop shop for...
A first-in-human, Phase 1 trial assessing the safety and immunogenicity of an investigational nanoparticle influenza vaccine designed to provide long-lasting protection against...
Almost 1 in 4 COVID-19 patients have another bacterial, viral or fungal infection simultaneously or subsequently, with such patients experiencing worse disease outcomes....
Start-up Vitalex Biosciences is manufacturing humanized monoclonal antibodies that would stem the spread of this fatal disease LOS ANGELES (May 13, 2021) —...
A Phase 2/3 trial to evaluate a new fully-human polyclonal antibody therapeutic targeted to SARS-CoV-2, called SAB-185, has begun enrolling non-hospitalized people with...
